Adagio Medical Holdings Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Adagio Medical Holdings Inc (ADGM) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Adagio Medical Holdings Inc vs Its Competitors
- Scale: Adagio Medical Holdings Inc ranks #196 of 246 companies by market capitalization in the Medical Equipment & Supplies industry, holding 0.0% of industry market cap.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
API endpoints for this dataset
Adagio Medical Holdings Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Adagio Medical Holdings inc | - | - | - | Yes |
| Competitors combined (57) | ||||
| High-Confidence Competitors (1) | - | |||
| Similar-Size Competitors (10) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
ADGM Stock Performance relative to its Competitors
ADGM Stock Performance relative to High-Confidence Competitors
ADGM Stock Performance relative to Similar-Size Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Axogen inc | 282.9% | Outperformed |
| 2 | Monogram technologies inc | 282.9% | Outperformed |
| 3 | Orthopediatrics Corp | 282.9% | Outperformed |
| 4 | Atricure Inc | 282.9% | Outperformed |
| 5 | Livanova Plc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Adagio Medical Holdings Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Adagio Medical Holdings Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Adagio Medical Holdings inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Adagio Medical Holdings inc |
1.35 | - |
 Abbott Laboratories |
198,002.64 | 46,585.00 |
 Intuitive Surgical Inc |
164,731.63 | 12,115.60 |
 Medtronic Plc |
134,729.88 | 37,542.00 |
 Stryker Corp |
128,905.28 | 26,300.00 |
 Boston Scientific Corporation |
64,817.28 | 21,070.00 |
| SUBTOTAL | 958,156.26 | 240,758.86 |
Sign in to see all competitors of Adagio Medical Holdings inc .
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Adagio Medical Holdings inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Adagio Medical Holdings Inc's Competitors Named by the Company
Competitive relationships identified from Adagio Medical Holdings Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Immunome Inc | Company report | 85% |
| Koninklijke Philips Nv | Company report | 85% |
| Meihua International Medical Technologies Co Ltd | Company report | 85% |
| Cvrx inc | Company report | 85% |
| Abiomed Inc | Company report | 85% |
| Shockwave Medical Inc | Company report | 85% |
| Penumbra Inc | Company report | 85% |
| Cardiovascular Systems Inc | Company report | 85% |
| Vaso Corporation | Company report | 85% |
| Orchestra Biomed Holdings Inc | Company report | 85% |
| Baxter International Inc | Company report | 85% |
| Vicarious Surgical Inc | Company report | 85% |
| Integra Lifesciences Holdings Corp | Company report | 85% |
| Transmedics Group Inc | Company report | 85% |
| Si bone inc | Company report | 85% |
| Zimvie Inc | Company report | 85% |
| Abbott Laboratories | Company report | 85% |
| Medinotec Inc | Company report | 85% |
| Bioventus Inc | Company report | 85% |
| Medtronic Plc | Company report | 85% |
| Procept Biorobotics Corporation | Company report | 85% |
| Smith and Nephew Plc | Company report | 85% |
| Alphatec Holdings Inc | Company report | 85% |
| Conformis inc | Company report | 85% |
| Fuse Medical Inc | Company report | 85% |
| Boston Scientific Corporation | Company report | 85% |
| Asensus Surgical Inc | Company report | 85% |
| Ir med Inc | Company report | 85% |
| Merit Medical Systems Inc | Company report | 85% |
| Paragon 28 inc | Company report | 85% |
| Non Invasive Monitoring Systems Inc | Company report | 85% |
| Orthopediatrics Corp | Company report | 85% |
| Atricure Inc | Company report | 85% |
| Globus Medical Inc | Company report | 85% |
| Edwards Lifesciences Corporation | Company report | 85% |
| Inari Medical Inc | Company report | 85% |
| Utah Medical Products Inc | Company report | 85% |
| Streamex Corp | Company report | 85% |
| Enovis Corp | Company report | 85% |
| Conmed Corporation | Company report | 85% |
| Surgalign Holdings Inc | Company report | 85% |
| Artivion Inc | Company report | 85% |
| Livanova Plc | Company report | 85% |
| Surmodics Inc | Company report | 85% |
| Orthofix Medical Inc | Company report | 85% |
| Catheter Precision Inc | Company report | 85% |
| Vapotherm Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Adagio Medical Holdings Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Adagio Medical Holdings Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Abbott Laboratories | Diabetes Care 16.79 % |
| Medtronic Plc | CARDIOVASCULAR 38.34 % |
| Stryker Corp | MedSurg and Neurotechnology 56.20 % |
| Boston Scientific Corporation | Cardiovascular 66.29 % |
| Becton Dickinson And Company | Medical Essentials 34.94 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Adagio Medical Holdings inc .
Adagio Medical Holdings Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Adagio Medical Holdings inc | 1 | - | -50,049 |
| Abbott Laboratories | 198,003 | 405,087 | 47,174 |
| Intuitive Surgical Inc | 164,732 | 711,803 | 174,578 |
| Medtronic Plc | 134,730 | 395,179 | 55,463 |
| Stryker Corp | 128,905 | 469,643 | 64,696 |
| Boston Scientific Corporation | 64,817 | 357,119 | 59,220 |
| PEERS TOTAL | 958,155 | 374,264 | 35,135 |
Sign in to see all peers for Adagio Medical Holdings inc .
Adagio Medical Holdings Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Abbott Laboratories | Non-US 57.70 % |
| Intuitive Surgical Inc | Geographic Distribution, Foreign 29.66 % |
| Medtronic Plc | United States 49.83 % |
| Stryker Corp | United States 75.92 % |
| Boston Scientific Corporation | United States 64.40 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sign in to see all peers for Adagio Medical Holdings inc .
Adagio Medical Holdings Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 218 companies in Adagio Medical Holdings Inc's industry classification, broader than the peer set above. Market cap in millions of $.Adagio Medical Holdings Inc ranks #196 of 218 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 624, indicating a unconcentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Intuitive Surgical Inc | 167,402 | 13.73 % |
| 2 | Medtronic Plc | 134,730 | 11.05 % |
| 3 | Stryker Corp | 129,341 | 10.61 % |
| 4 | 3m Company | 98,091 | 8.05 % |
| 5 | Boston Scientific Corporation | 1,234 | 5.2% |
| 6 | Becton Dickinson And Company | 1,234 | 5.2% |
| 7 | Edwards Lifesciences Corporation | 1,234 | 5.2% |
| 8 | Alcon inc | 1,234 | 5.2% |
| 9 | Resmed Inc | 1,234 | 5.2% |
| 10 | Medline Inc | 1,234 | 5.2% |
| 196 | Adagio Medical Holdings inc | 1 | 0.00 % |
Market cap and industry share for the rest of Adagio Medical Holdings Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-05.
Adagio Medical Holdings Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 191 | Valion Bio Inc | 2 | -78.34 % |
| 192 | Vycor Medical Inc | 2 | - |
| 193 | Envue Medical Inc | 2 | - |
| 194 | Icecure Medical Ltd | 1 | -96.59 % |
| 195 | Euda Health Holdings Limited | 1,234 | 12.3% |
| 196 | Adagio Medical Holdings inc | 1 | -93.82 % |
| 197 | Invo Fertility Inc | 1,234 | 12.3% |
| 198 | Agape Atp Corporation | 1,234 | 12.3% |
| 199 | Biotricity Inc | 1,234 | 12.3% |
| 200 | Co diagnostics Inc | 1,234 | 12.3% |
| 201 | Bluejay Diagnostics Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Adagio Medical Holdings Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-11-05. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Adagio Medical Holdings Inc's Valuation vs Competitive Position
Valuation multiples vs the Medical Equipment & Supplies industry average (342 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Medical Equipment & Supplies industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 38.2x | - |
| EV / EBITDA | 5.8x | 18.2x | -12.4x |
| P/B | 3.6x | 4.6x | -0.9x |
| Return on Equity | -34.33 % | industry aggregate | -46.31 % |
| Return on Invested Capital | -46.83 % | -6.87 % (avg) | -39.96 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Adagio Medical Holdings Inc's BCG Growth-Share Matrix
See Methodology: BCG Growth-Share Matrix for how relative share and growth are calculated and thresholded.
Adagio Medical Holdings Inc falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 8.9% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Adagio Medical Holdings Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 624 (see Industry Market Structure & Concentration above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Adagio Medical Holdings Inc's dedicated Suppliers and Customers pages, not here.
Adagio Medical Holdings Inc's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
Adagio Medical Holdings Inc falls in the Low attractiveness / Low strength cell: Harvest / Divest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Adagio Medical Holdings Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Return on equity 46.3 points below the industry aggregate.
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.00x).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
No rule matched.
Methodology: see Methodology: SWOT Analysis.
Adagio Medical Holdings Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Adagio Medical Holdings inc | 1.37 | 1.79 | 4.59 |
| Abbott Laboratories | 0.42 | 1.50 | 0.44 |
| Intuitive Surgical Inc | 1.33 | 4.37 | - |
| Medtronic Plc | 0.15 | 2.10 | 0.57 |
| Stryker Corp | 0.50 | 2.08 | 0.65 |
| Boston Scientific Corporation | 0.23 | 1.50 | 0.46 |
Sign in to see all peers for Adagio Medical Holdings inc .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Adagio Medical Holdings Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Adagio Medical Holdings inc | Q2 2026 | - | - |
| Abbott Laboratories | Q2 2026 | +13.0 % | -47.8 % |
| Intuitive Surgical Inc | Q3 2026 | +32.7 % | -26.3 % |
| Medtronic Plc | Q2 2026 | +13.7 % | +41.3 % |
| Stryker Corp | Q3 2026 | +7.6 % | -12.3 % |
| Boston Scientific Corporation | Q3 2026 | +1.4 % | -23.2 % |
| PEERS TOTAL | +7.8 % | +21.7 % |
Sign in to see all peers for Adagio Medical Holdings inc .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Adagio Medical Holdings Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Adagio Medical Holdings inc | Q2 2026 | - | -40.0 % |
| Abbott Laboratories | Q2 2026 | +9.7 % | -1.0 % |
| Intuitive Surgical Inc | Q3 2026 | +14.5 % | +7.3 % |
| Medtronic Plc | Q2 2026 | +13.8 % | -0.2 % |
| Stryker Corp | Q3 2026 | +3.0 % | +26.7 % |
| Boston Scientific Corporation | Q3 2026 | +12.3 % | -0.6 % |
Sign in to see all peers for Adagio Medical Holdings inc .
Adagio Medical Holdings Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Adagio Medical Holdings inc | - | - | - |
| Abbott Laboratories | 5.56% | 6.45% | 10.41% |
| Intuitive Surgical Inc | 14.71% | 16.30% | 16.99% |
| Medtronic Plc | 5.71% | 6.46% | 10.64% |
| Stryker Corp | 7.66% | 8.63% | 15.61% |
| Boston Scientific Corporation | 7.82% | 9.14% | 13.75% |
Sign in to see all peers for Adagio Medical Holdings inc .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Adagio Medical Holdings Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Adagio Medical Holdings inc | - | - |
| Abbott Laboratories | 36.53 | 4.25 |
| Intuitive Surgical Inc | 56.86 | 13.60 |
| Medtronic Plc | 308.35 | 3.59 |
| Stryker Corp | 35.68 | 4.90 |
| Boston Scientific Corporation | 18.94 | 3.08 |
| PEERS AVERAGE | 42.40 | 3.98 |
Sign in to see all peers for Adagio Medical Holdings inc .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.